Literature DB >> 307229

[Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].

A Franco, P Bourlard, C Massot, J Lecoeur, H Guidicelli, G Bessard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 307229

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN： 0301-1518


× No keyword cloud information.
  7 in total

Review 1.  Clinically significant drug interactions with agents specific for migraine attacks.

Authors:  M J Eadie
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Side-effects due to the intravenous infusion of erythromycin lactobionate.

Authors:  R Putzi; J Blaser; R Lüthy; R Wehrli; W Siegenthaler
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

3.  Severe vascular spasm due to erythromycin-ergotamine interaction.

Authors:  H Francis; A Tyndall; J Webb
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

Review 4.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

5.  Interaction of dihydroergotamine and triacetyloleandomycin in the minipig.

Authors:  M Martinet; J R Kiechel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

Review 6.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

Review 7.  Pharmacokinetic interactions of the macrolide antibiotics.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.